[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2575-2576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01513]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Microgenics 
Corporation Thermo Fisher Scientific

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before March 11, 2019. Such 
persons may also file a written request for a hearing on the 
application on or before March 11, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on 
October 23, 2018, Microgenics Corporation/Thermo Fisher Scientific 
located at 46500 Kato Rd., Fremont, California 94538, applied to be 
registered as an importer of the below listed basic classes of 
controlled substance listed in schedules I and II.

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Cathinone.................................  1235.........  I

[[Page 2576]]

 
Mephedrone (4-Methyl-N-methylcathinone)...  1248.........  I
Gamma Hydroxybutyric Acid.................  2010.........  I
Methaqualone..............................  2565.........  I
Mecloqualone..............................  2572.........  I
2-(1-(4-fluorobenzyl)-1Hindazole-3-         7021.........  I
 carboxamido)-3-methylbutanoate.
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-  7023.........  I
 2-yl)-1-pentyl-1H-indazole-3-carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-         7031.........  I
 >oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-     7032.........  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-    7033.........  I
 indazole-3-carboxamido)-3-
 methylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-      7035.........  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- 7048.........  I
 1H-indazole-3-carboxamide.
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)  7201.........  I
 indole).
Lysergic acid diethylamide................  7315.........  I
Marihuana.................................  7360.........  I
Tetrahydrocannabinols.....................  7370.........  I
3,4-Methylenedioxyamphetamine.............  7400.........  I
3,4-Methylenedioxy-N-ethylamphetamine.....  7404.........  I
3,4-Methylenedioxymethamphetamine.........  7405.........  I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine   7518.........  I
 (2C-I).
MDPV (3,4-Methylenedioxypyrovalerone).....  7535.........  I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-        7538.........  I
 methoxybenzyl) ethanamine (25I-NBOMe).
Butylone..................................  7541.........  I
Pentylone.................................  7542.........  I
alpha-pyrrolidinopentiophenone ([alpha]-    7545.........  I
 PVP).
Normorphine...............................  9313.........  I
AH-7921 (3,4-dichloro-N-[(1-                9551.........  I
 dimethylamino)cyclohexylmethyl]benzamide)
 ).
Acetylmethadol............................  9601.........  I
Alphamethadol.............................  9605.........  I
Ketobemidone..............................  9628.........  I
Noracymethadol............................  9633.........  I
Para-Fluorofentanyl.......................  9812.........  I
3-Methylfentanyl..........................  9813.........  I
Alpha-methylfentanyl......................  9814.........  I
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821.........  I
 yl)-N-phenylacetamide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-  9825.........  I
 phenylacetamide.
3-Methylthiofentanyl......................  9833.........  I
Cyclopropyl Fentanyl......................  9845.........  I
Fentanyl related-compounds as defined in    9850.........  I
 21 CFR 1308.11&h).
Amphetamine...............................  1100.........  II
Methamphetamine...........................  1105.........  II
Methylphenidate...........................  1724.........  II
Amobarbital...............................  2125.........  II
Pentobarbital.............................  2270.........  II
Secobarbital..............................  2315.........  II
Phencyclidine.............................  7471.........  II
Cocaine...................................  9041.........  II
Codeine...................................  9050.........  II
Dihydrocodeine............................  9120.........  II
Oxycodone.................................  9143.........  II
Hydromorphone.............................  9150.........  II
Ecgonine..................................  9180.........  II
Hydrocodone...............................  9193.........  II
Levorphanol...............................  9220.........  II
Meperidine................................  9230.........  II
Meperidine intermediate-B.................  9233.........  II
Methadone.................................  9250.........  II
Dextropropoxyphene, bulk (non-dosage        9273.........  II
 forms).
Morphine..................................  9300.........  II
Thebaine..................................  9333.........  II
Levo-alphacetylmethadol...................  9648.........  II
Oxymorphone...............................  9652.........  II
Carfentanil...............................  9743.........  II
Tapentadol................................  9780.........  II
Fentanyl..................................  9801.........  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
feasibility studies for new products and cross reactivity studies for 
existing products. The products will serve as raw materials for InVitro 
Diagnostic quantitative assay.

    Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01513 Filed 2-6-19; 8:45 am]
 BILLING CODE 4410-09-P